Lassmann H. Pathology of inflammatory diseases of the nervous system: human disease versus animal models. Glia. 2020;68(4):830–44.
Absinta M, Lassmann H, Trapp BD. Mechanisms underlying progression in multiple sclerosis. Curr Opin Neurol. 2020;33(3):277–85.
Article PubMed PubMed Central Google Scholar
Bierhansl L, Hartung HP, Aktas O, Ruck T, Roden M, Meuth SG. Thinking outside the box: non-canonical targets in multiple sclerosis. Nat Rev Drug Discov. 2022;21(8):578–600.
Article PubMed PubMed Central Google Scholar
Kirschner P, Pawlitzki M, Hartung HP, Meuth SG. Immunology of multiple sclerosis: an update. Curr Opin Neurol. 2025;38(3):180–7.
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–72.
Article PubMed PubMed Central Google Scholar
Berndt C, Alborzinia H, Amen VS, Ayton S, Barayeu U, Bartelt A, et al. Ferroptosis in health and disease. Redox Biol. 2024;75:103211.
Article PubMed PubMed Central Google Scholar
Kemp K, Redondo J, Hares K, Rice C, Scolding N, Wilkins A. Oxidative injury in multiple sclerosis cerebellar grey matter. Brain Res. 2016;1642:452–60.
Hu CL, Nydes M, Shanley KL, Morales Pantoja IE, Howard TA, Bizzozero OA. Reduced expression of the ferroptosis inhibitor glutathione peroxidase-4 in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurochem. 2019;148(3):426–39.
Li X, Chu Y, Ma R, Dou M, Li S, Song Y, et al. Ferroptosis as a mechanism of oligodendrocyte loss and demyelination in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2022;373:577995.
Hametner S, Dal Bianco A, Trattnig S, Lassmann H. Iron related changes in MS lesions and their validity to characterize MS lesion types and dynamics with ultra-high field magnetic resonance imaging. Brain Pathol. 2018;28(5):743–9.
Article PubMed PubMed Central Google Scholar
Dunham J, Bauer J, Campbell GR, Mahad DJ, van Driel N, van der Pol SMA, et al. Oxidative injury and iron redistribution are pathological hallmarks of marmoset experimental autoimmune encephalomyelitis. J Neuropathol Exp Neurol. 2017;76(6):467–78.
Lassmann H, van Horssen J. Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions. Biochim Biophys Acta. 2016;1862(3):506–10.
Stojkovic L, Djordjevic A, Stefanovic M, Stankovic A, Dincic E, Djuric T, et al. Circulatory indicators of lipid peroxidation, the driver of ferroptosis, reflect differences between relapsing-remitting and progressive multiple sclerosis. Int J Mol Sci. 2024;25:11024. https://doi.org/10.3390/ijms252011024.
Article PubMed PubMed Central Google Scholar
Van San E, Debruyne AC, Veeckmans G, Tyurina YY, Tyurin VA, Zheng H, et al. Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression. Cell Death Differ. 2023;30(9):2092–103.
Article PubMed PubMed Central Google Scholar
Dietrich M, Hecker C, Nasiri M, Samsam S, Issberner A, Kohne Z, et al. Neuroprotective properties of dimethyl fumarate measured by optical coherence tomography in Non-inflammatory animal models. Front Neurol. 2020;11:601628.
Kocur M, Schneider R, Pulm AK, Bauer J, Kropp S, Gliem M, et al. IFNbeta secreted by microglia mediates clearance of Myelin debris in CNS autoimmunity. Acta Neuropathol Commun. 2015;3:20.
Article PubMed PubMed Central Google Scholar
Lepka K, Volbracht K, Bill E, Schneider R, Rios N, Hildebrandt T, et al. Iron-sulfur glutaredoxin 2 protects oligodendrocytes against damage induced by nitric oxide release from activated microglia. Glia. 2017;65(9):1521–34.
Popova NV. [Transplancental effect of ortho-aminoazotoluene on organ cultures of embryonal liver from mouse lines C57BL and CBA]. Biull Eksp Biol Med. 1977;83(6):732–4.
Lowin T, Apitz M, Anders S, Straub RH. Anti-inflammatory effects of N-acylethanolamines in rheumatoid arthritis synovial cells are mediated by TRPV1 and TRPA1 in a COX-2 dependent manner. Arthritis Res Ther. 2015;17:321.
Article PubMed PubMed Central Google Scholar
Albrecht P, Bouchachia I, Goebels N, Henke N, Hofstetter HH, Issberner A, et al. Effects of dimethyl fumarate on neuroprotection and immunomodulation. J Neuroinflammation. 2012;9:163.
Article PubMed PubMed Central Google Scholar
Linker RA, Lee DH, Ryan S, van Dam AM, Conrad R, Bista P, et al. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain. 2011;134(Pt 3):678–92.
Yousuf MS, Moreno MM, Woodall BJ, Thakur V, Li J, He L, et al. Diroximel fumarate acts through Nrf2 to attenuate methylglyoxal-induced nociception in mice and decrease ISR activation in DRG neurons. Diabetes. 2025;74:827–37.
Zhu H, Yang Y, Duan Y, Zheng X, Lin Z, Zhou J. Nrf2/FSP1/CoQ10 axis-mediated ferroptosis is involved in sodium aescinate-induced nephrotoxicity. Arch Biochem Biophys. 2024;759:110100.
Ufer C, Borchert A, Kuhn H. Functional characterization of cis- and trans-regulatory elements involved in expression of phospholipid hydroperoxide glutathione peroxidase. Nucleic Acids Res. 2003;31(15):4293–303.
Article PubMed PubMed Central Google Scholar
Jhelum P, Zandee S, Ryan F, Zarruk JG, Michalke B, Venkataramani V, et al. Ferroptosis induces detrimental effects in chronic EAE and its implications for progressive MS. Acta Neuropathol Commun. 2023;11(1):121.
Article PubMed PubMed Central Google Scholar
Jhelum P, Santos-Nogueira E, Teo W, Haumont A, Lenoel I, Stys PK, et al. Ferroptosis mediates cuprizone-induced loss of oligodendrocytes and demyelination. J Neurosci. 2020;40(48):9327–41.
Article PubMed PubMed Central Google Scholar
Saverio V, Ferrario E, Monzani R, Gagliardi M, Favero F, Cora D, et al. AKRs confer oligodendrocytes resistance to differentiation-stimulated ferroptosis. Redox Biol. 2025;79:103463.
Cheng H, Wang P, Wang N, Dong W, Chen Z, Wu M, et al. Neuroprotection of NRF2 against ferroptosis after traumatic brain injury in mice. Antioxidants. 2023. https://doi.org/10.3390/antiox12030731.
Article PubMed PubMed Central Google Scholar
Qi D, Chen P, Bao H, Zhang L, Sun K, Song S, et al. Dimethyl fumarate protects against hepatic ischemia-reperfusion injury by alleviating ferroptosis via the NRF2/SLC7A11/HO-1 axis. Cell Cycle. 2023;22(7):818–28.
Yan N, Xu Z, Qu C, Zhang J. Dimethyl fumarate improves cognitive deficits in chronic cerebral hypoperfusion rats by alleviating inflammation, oxidative stress, and ferroptosis via NRF2/ARE/NF-kappaB signal pathway. Int Immunopharmacol. 2021;98:107844.
Yang Y, Cai F, Zhou N, Liu S, Wang P, Zhang S, et al. Dimethyl fumarate prevents ferroptosis to attenuate acute kidney injury by acting on NRF2. Clin Transl Med. 2021;11(4):e382.
Article PubMed PubMed Central Google Scholar
Zhu X, Lu H, Jia H, Wei X, Xue J, Li W, et al. Ferrostatin-1 reduces the inflammatory response of rheumatoid arthritis by decreasing the antigen presenting function of fibroblast-like synoviocytes. J Transl Med. 2025;23(1):280.
Article PubMed PubMed Central Google Scholar
Liu Y, Luo X, Chen Y, Dang J, Zeng D, Guo X, et al. Heterogeneous ferroptosis susceptibility of macrophages caused by focal iron overload exacerbates rheumatoid arthritis. Redox Biol. 2024;69:103008.
Comments (0)